147 related articles for article (PubMed ID: 36756100)
1. Experiences and Outcomes in Olfactory Neuroblastoma Over A Decade at a Tertiary Cancer Center.
Korra H; Gandi JB; Nanuvala P; Ardha A
South Asian J Cancer; 2022 Oct; 11(4):336-339. PubMed ID: 36756100
[No Abstract] [Full Text] [Related]
2. An atypical Esthesioneuroblastoma of the sphenoid sinus: a case report.
Touihmi S; Horrane I; Rkain I
Ann Med Surg (Lond); 2023 May; 85(5):2029-2033. PubMed ID: 37228980
[TBL] [Abstract][Full Text] [Related]
3. Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapy.
Gumpel E; Moore AS; Simpson DJ; Hoffmann KL; Taylor DP
Aust Vet J; 2017 Jul; 95(7):227-231. PubMed ID: 28653386
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.
Manthuruthil C; Lewis J; McLean C; Batra PS; Barnett SL
World Neurosurg; 2016 Jun; 90():1-5. PubMed ID: 26899467
[TBL] [Abstract][Full Text] [Related]
5. Multimodality Treatment of Pediatric Esthesioneuroblastoma.
Venkatramani R; Pan H; Furman WL; Marron JM; Haduong J; Friedrich-Medina P; Mahajan A; Bavle A; Wu H; Chintagumpala M
Pediatr Blood Cancer; 2016 Mar; 63(3):465-70. PubMed ID: 26514449
[TBL] [Abstract][Full Text] [Related]
6. [The results of combined treatment patients with olfactory neuroblastoma in material of Cancer Center in Warsaw].
Jarząbski A; Kiprian D; Szutkowski Z; Kawecki A; Michalski W
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):93-7. PubMed ID: 22000257
[TBL] [Abstract][Full Text] [Related]
7. Importance of neoadjuvant chemotherapy in olfactory neuroblastoma treatment: Series report and literature review.
Bartel R; Gonzalez-Compta X; Cisa E; Cruellas F; Torres A; Rovira A; Manos M
Acta Otorrinolaringol Esp (Engl Ed); 2018; 69(4):208-213. PubMed ID: 29061289
[TBL] [Abstract][Full Text] [Related]
8. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
9. Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance.
Schmidt C; Potter N; Porceddu S; Panizza B
J Laryngol Otol; 2017 Jul; 131(S2):S29-S34. PubMed ID: 27917732
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
11. Esthesioneuroblastoma: a case report.
Shukla RC; Singh PK; Senthil S; Pathak R
Nepal Med Coll J; 2010 Jun; 12(2):128-32. PubMed ID: 21222414
[TBL] [Abstract][Full Text] [Related]
12. Olfactory neuroblastoma: 15 years of experience.
Kondo N; Takahashi H; Nii Y; Nagao J
Anticancer Res; 2012 May; 32(5):1697-703. PubMed ID: 22593448
[TBL] [Abstract][Full Text] [Related]
13. Olfactory neuroblastoma treated by endoscopic surgery followed by combined external beam radiation and gamma knife for optic nerve and chiasm sparing: a case report.
Jiang HZ; Elaimy AL; Jones GC; Mackay AR; Fairbanks RK; Lamoreaux WT; Demakas JJ; Cooke BS; Lee CM
Case Rep Med; 2011; 2011():765645. PubMed ID: 22110517
[TBL] [Abstract][Full Text] [Related]
14. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.
Mays AC; Bell D; Ferrarotto R; Phan J; Roberts D; Fuller CD; Frank SJ; Raza SM; Kupferman ME; DeMonte F; Hanna EY; Su SY
Laryngoscope; 2018 Jun; 128(6):1274-1280. PubMed ID: 29226334
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy of olfactory neuroblastoma--report of 5 patients].
Pan H; Zhang HW
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):222-4. PubMed ID: 3743353
[TBL] [Abstract][Full Text] [Related]
17. Esthesioneuroblastoma: the impact of treatment modality.
Chao KS; Kaplan C; Simpson JR; Haughey B; Spector GJ; Sessions DG; Arquette M
Head Neck; 2001 Sep; 23(9):749-57. PubMed ID: 11505485
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.
Harvey RJ; Nalavenkata S; Sacks R; Adappa ND; Palmer JN; Purkey MT; Schlosser RJ; Snyderman C; Wang EW; Woodworth BA; Smee R; Havas T; Gallagher R
Head Neck; 2017 Dec; 39(12):2425-2432. PubMed ID: 28945299
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.
Sun Y; Huang Q; Cui S; Wang M; Zhang N; Zhang S; Yang B; Qiu E; Huang Z; Zhou B
World Neurosurg; 2021 Jul; 151():e58-e67. PubMed ID: 33798777
[TBL] [Abstract][Full Text] [Related]
20. Complications of Advanced Kadish Stage Esthesioneuroblastoma: Single Institution Experience and Literature Review.
Palejwala SK; Sharma S; Le CH; Chang E; Lemole M
Cureus; 2017 May; 9(5):e1245. PubMed ID: 28620574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
